Nursing of paronychia caused by Erlotinib therapy for advanced non-small-cell lung cancer patients
10.3760/cma.j.issn.1672-7088.2016.14.010
- VernacularTitle:盐酸厄洛替尼治疗非小细胞肺癌所致甲沟炎的护理
- Author:
Xiaochen LIU
;
Yu WANG
;
Xiaodan LIU
;
Qiying TIAN
- Publication Type:Journal Article
- Keywords:
Nursing care;
Carcinoma,non-small-cell lung;
Paronychia;
Erlotinib
- From:
Chinese Journal of Practical Nursing
2016;32(14):1079-1081
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the nursing interventions of paronychia caused by Erlotinib therapy for advanced non-small-cell lung cancer patients. Methods A total of 78 patients who diagnosed as advanced non-small-cell lung cancer and treated by oral Erlotinib were selected. The occurrence of paronychia among them was observed and the curative effect of certain nursing interventions on paronychia was evaluated. Results Seven out of 78 cases occurred various degrees of paronychia,and certain nursing interventions could effectively prevent and treat paronychia. Conclusions Targeted drug Erlotinib in patients with advanced non-small cell lung cancer can cause adverse reactions like paronychia,but effective nursing interventions are capable of controlling the adverse reactions, thus further improve the quality of life and ensure the smooth progress of treatment.
